Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency.
CONCLUSIONS: In the setting of persistent diabetic macular edema, fluocinolone acetonide significantly reduces the therapeutic burden, while maintaining best-corrected visual acuity and improving the central retinal thickness. In patient-centered discussions, judiciously employing fluocinolone acetonide should be performed to mitigate this therapeutic burden for patients.
PMID: 31964171 [PubMed - as supplied by publisher]
Source: European Journal of Ophthalmology - Category: Opthalmology Authors: Adams OE, Schechet SA, Hariprasad SM Tags: Eur J Ophthalmol Source Type: research
More News: Dexamethasone | Diabetes | Endocrinology | Eye Implants | Eyes | Opthalmology | Statistics | Study | Vitamin A